Emergence of MRSA Sequence Type 398 in Horses

In the Netherlands in 2005, a small number of unexpected methicillin-resistant Staphylococcus aureus (MRSA) infections in people with pig contact led to identification of a novel MRSA clone, sequence type (ST) 398. This clone was quickly called “‘livestock-associated” MRSA, although recent evidence suggests that it originated in humans as a methicillin-susceptible strain that subsequently moved to pigs, became methicillin-resistant, and lost some human-adaptive traits.

Nonetheless, whatever it is termed, ST398 MRSA is an important issue in people and animals in some regions. The organism has been identified in pigs (and to a lesser degree other livestock such as cattle and poultry) worldwide and is commonly found in people that have contact with livestock. In some northern European countries, it is the leading cause of MRSA infection in people.

Equine MRSA infections were first reported in the late 1990s, and it soon became apparent that MRSA was endemic in the horse population in many regions, being found in a small percentage (typically <3%) of healthy horses and causing sporadic infections and outbreaks.

Abnormally high rates of MRSA colonization of horse owners and equine veterinarians have also been reported, along with smaller numbers of zoonotic infections. Until the late 2000s, the vast majority of MRSA isolates from horses were common human epidemic clones (e.g. ST8), suggesting that equine MRSA was ultimately human in origin.

Yet recent years have ushered in a potential new concern, with identification of ST398 in horses. The strain has now been reported in horses in many European countries as well as in a single Canadian horse. Zoonotic infection from a horse has also been reported. Highly variable colonization rates (0.5-11%) have been described, and ST398 has displaced other strains to become the leading cause of MRSA infection in horses in some areas of Europe. As is typical for any MRSA strain, a wide range of clinical infections has been reported, including skin and soft tissue infections, surgical site infections, pneumonia, catheter site infections, mastitis (infection of the mammary gland), and metritis (inflammation of the uterus).

Whether the emergence of ST398 in horses indicates a clinically relevant change for the horse population, a concern restricted to certain regions or farm types, or simply a shift in predominant strains with limited clinical relevance remains to be seen. While ST398 appears to be rare (at this time) in horses outside of northern Europe, the highly mobile nature of the horse population indicates a potential for horses to assist with global dissemination of this animal and human pathogen.

Horse owners and veterinarians should be aware of the risk of MRSA (ST398 and others), and use:

  1. Basic infection control practices at all times;
  2. Enhanced infection control practices for any animal with an infection;
  3. Antimicrobials prudently; and
  4. Bacterial culture and susceptibility testing routinely on animals with opportunistic infections.

Emergence of this livestock-associated MRSA clone also highlights the often-overlooked potential for pathogen exposure of horses that have direct or indirect contact with food animals.

CONTACT: J. Scott Weese, DVM, DVSc, Dipl. ACVIM—519/824-4120, Ext. 54064—jsweese@uoguelph.ca—University of Guelph Ontario Veterinary College, Guelph, Ontario, Canada

This is an excerpt from Equine Disease Quarterly, funded by underwriters at Lloyd's, London, brokers, and their Kentucky agents.

About the Author

Equine Disease Quarterly

Equine Disease Quarterly is a quarterly equine disease research newsletter published by the University of Kentucky's Gluck Equine Research Center, and funded by underwriters at Lloyd's of London, brokers, and their agents.

Stay on top of the most recent Horse Health news with FREE weekly newsletters from TheHorse.com. Learn More

Free Newsletters

Sign up for the latest in:

From our partners